Enforcement Report - Week of November 13, 2024
13 Nov 2024 //
FDA
Australia`s Mayne Pharma sues Sun Pharma over patent infringement
24 Jul 2024 //
REUTERS
Mayne Pharma to Present at the 42nd Annual J.P. Morgan Healthcare Conference
29 Dec 2023 //
GLOBENEWSWIRE
Teva recalls fentanyl buccal tablets produced for Mayne Pharma
01 May 2023 //
FIERCE PHARMA
Dr Reddy`s to acquire Mayne Pharma US generic portfolio for $115 million
27 Feb 2023 //
ECONOMIC TIMES
TherapeuticsMD Completes Transaction to License Its Products to Mayne Pharma
03 Jan 2023 //
BUSINESSWIRE
TherapeuticsMD to slash its entire workforce of 212 people
10 Dec 2022 //
FIERCEPHARMA
TherapeuticsMD Announces Definitive Agreements to License its Products to Mayne
05 Dec 2022 //
BUSINESSWIRE
Mayne Pharma`s Generic Fentanyl Citrate Receives Approval in the U.S.
22 Aug 2022 //
FDA
Mayne Pharma Generic Haloette Receives Approval in the U.S.
05 Aug 2022 //
FDA
Enforcement Report - Week of June 29, 2022
29 Jun 2022 //
FDA
Mayne Pharma Announced As Recipient Of $4.8M Federal Government Grant
09 May 2022 //
MAYNEPHARMA
Enforcement Report - Week of January 26, 2022
26 Jan 2022 //
FDA
Mayne Pharma`s Generic Morphine Sulphate Receives Approval in the U.S.
12 Jan 2022 //
FDA
Alembic Pharma bags FDA approval for Doxycycline Hyclate delayed-release tablets
04 Jan 2022 //
EXPRESS PHARMA
Metrics Contract Services Adds New Equipment
15 Oct 2021 //
CONTRACTPHARMA
Metrics Contract Services Signs Development & Manufacturing Agreement with ESSA
08 Oct 2021 //
CONTRACTPHARMA
Mithra Provides FDA Update on Myring
06 Oct 2021 //
MARKETSCREENER
Mayne Pharma`s Generic Morphine Sulfate Receives Approval In US
29 Jun 2021 //
FDA
Mayne Pharma Inc`s Generic Morphine Sulfate Receives Approval In US
02 Jun 2021 //
FDA
New Efficacy Data Reinforces NEXTSTELLIS® Benefits Across Patient Populations
30 Apr 2021 //
PRNEWSWIRE
Mayne Pharma and Mithra Announce FDA Approval of New Oral Contraceptive Estelle®
16 Apr 2021 //
PRESS RELEASE
U.S. FDA Approves NEXTSTELLIS®, New Oral Contraceptive
16 Apr 2021 //
PRNEWSWIRE
Metrics Names Stephanie Emory Associate Director of Pharma Development
15 Apr 2021 //
NEUROOTHERS
New Data Show NEXTSTELLIS Has Selective Impact On Endocrine Markers
08 Mar 2021 //
PRNEWSWIRE
Mayne Pharma launches another generic oral contraceptive
04 Mar 2021 //
PRNEWSWIRE
New Data On Mayne Pharma`s Tolsura® Presented At IDWeek 2020
26 Oct 2020 //
PRNEWSWIRE
Metrics Contract Services Expands Business Development Team
21 Oct 2020 //
CONTRACTPHARMA
Metrics Contract Services to Expand Greenville Manufacturing Facility
22 Sep 2020 //
PHARMATECH
Mayne Pharma’s Generic Chlorpromazine Hydrochloride Receives Approval In US
02 Sep 2020 //
FDA
Mayne Pharma’s Generic Chlorzoxazone Receives Approval In US
29 Jul 2020 //
FDA
Mayne Pharma Launches Chlorzoxazone Tablet in the United States
28 Jul 2020 //
PRNASIA
Mayne Pharma Launches Chlorzoxazone Tablet in the United States
27 Jul 2020 //
PRNEWSWIRE
Mayne Pharma Launches Chlorzoxazone Tablet in the United States
27 Jul 2020 //
PRNASIA
Mayne Pharma’s Generic Chlorzoxazone Receives Approval In US
25 Jul 2020 //
FDA
Mayne Pharma’s Generic Amphetamine Sulfate Receives Approval In US
18 Jul 2020 //
FDA
Mayne Pharma Announces FDA Filing Acceptance of NDA for E4/DRSP in the US
24 Jun 2020 //
PRNEWSWIRE
Mayne Pharma Announces FDA Filing Acceptance of New Drug Application for E4/DRSP
23 Jun 2020 //
PRNASIA
Australian firm Mayne Pharma launches migraine drug in US
25 May 2020 //
BIOSPECTRUMASIA
Mayne Pharma launches BAC 300 capsules in the United States
22 May 2020 //
PRNEWSWIRE
Mayne Pharma launches BAC 300 capsules in the United States
21 May 2020 //
PRNASIA
Mayne Pharma Submits New Drug Application for E4/DRSP to the FDA
16 Apr 2020 //
PR NEWSWIRE
Mayne Pharma Submits New Drug Application for E4/DRSP to the FDA
15 Apr 2020 //
PR NEWSWIRE
Morton Grove`s Withdrawal of Approval of 21 Abbreviated New Drug Applications
02 Dec 2019 //
FEDERALREGISTER
Metrics Completes Japanese Regulatory Inspection
19 Nov 2019 //
CONTRACT PHARMA
Mayne, Mithra bring novel oral contraception in the US
02 Oct 2019 //
PRNASIA
Mayne Pharma’s Generic Exemestane Receives Approval In US
13 Aug 2019 //
FDA
Setback For Dr. Reddy’s As U.S. FDA Hands Out Complete Response Letter
13 Aug 2019 //
BLOOMBERGQUINT
Mayne Pharma launches anti-plaque psoriasis agent in US
13 Feb 2019 //
BIOSPECTRUM
HedgePath Pharms, Mayne Pharma Enter Collaboration and Funding Agreements
17 Dec 2018 //
PR NEWSWIRE
Metrics Contract Services Announces Serialization Capabilities at Greenville
12 Nov 2018 //
PR NEWSWIRE
Mayne Pharma Acquires FDA-approved halobetasol foam
26 Oct 2018 //
PR NEWSWIRE
Mayne Pharma Issues Recall of all batches of LINEZOLID MYX injection
31 Aug 2018 //
TGA
Mayne Pharma opens $80m facility, expands CDMO offering
20 Apr 2018 //
IN PHARMATECHNOLOGY
Mayne Pharma debuts $80M solid dose plant in North Carolina
18 Apr 2018 //
FIERCE PHARMA
Enforcement Report - Week of April 11, 2018
11 Apr 2018 //
FDA
Mayne pharma launches generic version of Monodox in Australia
19 Mar 2018 //
BIOSPECTRUM